Addendum II to 62nd edition IATA DGR
ICAO has issued a further addendum to the 2021-2022 edition of the Technical Instructions. The ICAO amends special provision A220 to modify the application to be for COVID-19 pharmaceuticals and not just COVID-19 vaccines. A220 has also been expanded to except the application of the lithium battery mark and consequently the compliance statement on the air waybill to packagings for the COVID-19 pharmaceuticals that are accompanied by lithium battery-powered data loggers and/or cargo tracking devices when being shipped for use or re-use.
There are also changes to operator variations that have been advised and which have been included in the addendum.
DGR62-AddendumII-RU-23-February-2021-2
DGR62-AddendumII-ES-23-February-2021-2
DGR62-AddendumII-FR-23-February-2021-2
